Zacks Investment Research | Dec 09, 2019 10:04PM ET
Omnicell, Inc. (NASDAQ:OMCL) recently made a significant progress with implementation of professional IT services within medication management and adherence. The company has partnered with global professional services firm Huron to provide outcome-based professional solutions for customers adopting Omnicell technology. However, financial terms of the deal have been kept under wraps.
Per the company, these days, healthcare systems are facing challenges to optimize operations, improve clinical outcomes and deliver a more consumer-centric healthcare experience.Accordingly, the requirement for this kind of professional IT services in the field of medication management and adherence is rising by the day.
However, growing complexity of technology induces more scope for mishaps, pitfalls and mismanagement, causing overall failure of the project. According to a study by the IT Research firm The Standish Group, only 29% of healthcare IT projects is considered successful.
Recognizing this scenario and realizing the importance of a seamless implementation and integration experience, Omnicell has involved Huron to offer customers dedicated expertise. Per the company, this will help drive faster adoption of Omnicell technology solutions and achieve better clinical plus financial outcomes.
Industry Prospects
Going by a Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.